JFG
IMUX icon

Jefferies Financial Group’s Immunic IMUX Stock Holding History

Jefferies Financial Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,280
Closed -$59.9K – 1784
2022
Q4 		$59.9K Buy
+4,280
New +$117K ﹤0.01% 1403

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Financial Group's IMUX Position: Q3 2024 in Review

Jefferies Financial Group sold out of Immunic (IMUX) in Q3 2024, closing a stake of 33,177 shares — an estimated $368K sold.

Jefferies Financial Group first reported a position in IMUX in Q4 2022 and held it in 2 quarters. The position peaked at $479K in Q4 2022. 61 funds tracked by Wall St. Rank hold IMUX as of Q3 2024.

  • Jefferies Financial Group reported no remaining Immunic position as of Q3 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 33,177 Immunic shares in Q3 2024, an estimated $368K.
  • Jefferies Financial Group first reported a position in Immunic in Q4 2022 and held it in 2 quarters.
  • Jefferies Financial Group's Immunic position peaked at $479K in Q4 2022.
  • 61 funds tracked by Wall St. Rank held Immunic as of Q3 2024.

Based on Jefferies Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.